Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $128

Deutsche Bank analyst George Hill has maintained a 'Buy' rating on HealthEquity (NASDAQ: HQY) and increased the price target from $120 to $128. This adjustment reflects a positive outlook for the company's performance in the market.